Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2005
12/27/2005US6979764 Transgenic seeds, plants, tissue culture, protoplasts; crossbreeding, backcrossing; male sterility, resistant to herbicide, insect and disease; modifying metabolism of fatty acid, phytic acid or carbohydrate
12/27/2005US6979763 Hybrid maize plant & seed 38G60
12/27/2005US6979761 Soybean cultivar S030159
12/27/2005US6979759 Soybean variety 93B09
12/27/2005US6979733 Comprises nucleotide sequences coding biocatalyst polypeptide for hydrolysis of epoxides and arene oxides into diols such as glycidol and atenolol; antiinflammatory/hypotensive agents
12/27/2005US6979557 Comprise olignucleotide sequences associated with translation initiation for analyzing the function of polypeptide
12/27/2005US6979539 Regulation of endogenous gene expression in cells using zinc finger proteins
12/27/2005US6979443 Chemokine α-6
12/27/2005US6979308 Bioreactor design and process for engineering tissue from cells
12/27/2005CA2295594C A method of reducing signal coupling in a connector, a connector and a cable including such a connector
12/22/2005WO2005121342A1 Recombinant enterotoxin c and vaccine with the use of the same
12/22/2005WO2005121340A1 Novel galectin 8 modification protein and use thereof
12/22/2005WO2005121338A1 Anti-perp antibody
12/22/2005WO2005121335A1 Episomal fusion gene
12/22/2005WO2005121325A1 Heart and skeletal muscle inflammation (hsmi) virus
12/22/2005WO2005121324A1 Es cell mutation method and system
12/22/2005WO2005121323A2 Methods for ex vivo propagation of somatic hair follicle stem cells
12/22/2005WO2005121322A1 Enzymatic modification of cell-surface h antigen by glycosyltransferases
12/22/2005WO2005121321A2 Compositions comprising female germline stem cells and methods of use thereof
12/22/2005WO2005121320A1 Autonomouos replication promoter for stem cells
12/22/2005WO2005121319A1 Methods for production of mesodermal lineage cells
12/22/2005WO2005121318A2 Neural stem cells
12/22/2005WO2005121317A2 Method for obtaining mesenchymal stem cells
12/22/2005WO2005121316A1 Tissue material and muscle derived matrix
12/22/2005WO2005121176A1 Angiogenesis-inhibiting chimeric protein and the use
12/22/2005WO2005120701A1 Stable composite material comprising supported porous gels
12/22/2005WO2005120576A2 Composition and method for improving pancreatic islet cell survival
12/22/2005WO2005120575A1 Method of regenerating follicles by inhibiting gene capable of inhibting follicle formation or activating gene capable of inducing follicle formation
12/22/2005WO2005096706A3 Antibody to 5'-deoxy-5'-methylthioadenosine and uses thereof
12/22/2005WO2005078108A3 Stress resistant plants
12/22/2005WO2005069969A3 Mutant sodium channel nav1.7 and methods related thereto
12/22/2005WO2005067477A3 Anti-human lymphotoxin alpha antibodies, compositions, methods and uses
12/22/2005WO2005013912A3 Anti-fcrn antibodies for treatment of auto/allo immune conditions
12/22/2005WO2004082370A3 Cardiac-preferred genetic alteration of transgenic rabbits
12/22/2005WO2004070004A3 Rat receptor tyrosine kinase, kdr
12/22/2005WO2004048595A3 Vascular-preferred promoters
12/22/2005WO2003057856A3 Dominant negative proteins and methods thereof
12/22/2005WO2002083874A3 Endothelial cell expression patterns
12/22/2005US20050283862 Inbred corn line PHB1V
12/22/2005US20050283858 Brassica AHAS genes and gene alleles that provide resistance to imidazolinone herbicides
12/22/2005US20050283854 Recombinant vectors for use in position-independent transgene expression within chromatin
12/22/2005US20050283853 Methods and genetic compositions to limit outcrossing and undesired gene flow in crop plants
12/22/2005US20050283852 Specific genetic modification of the activity of trehalose-6-phosphate synthase and expression in a homologous or heterologous environment
12/22/2005US20050283851 Novel genes encoding proteins involved in proanthocyanidin synthesis
12/22/2005US20050283848 Expression of eukaryotic peptides in plant plastids
12/22/2005US20050283845 Method for producing non-human mammal having RNAi phenotype
12/22/2005US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/22/2005US20050282764 Method of identifying nucleic acid compositions for muting expression of a gene
12/22/2005US20050282740 Methods and compositions for regulating protein-protein interactions
12/22/2005US20050282282 Methods of use of viral vectors to deliver antigen to dendritic cells
12/22/2005US20050282277 Methods of increasing platelet and hematopoietic stem cell production
12/22/2005US20050282276 Cell fractions containing cells capable of differentiating into neural cells
12/22/2005US20050282275 Adipose-derived stem cells and lattices
12/22/2005US20050282274 Osteoblast precursors from human embryonic stem cells
12/22/2005US20050282273 Medium and methods for culturing of avian primordial germ cells
12/22/2005US20050282272 inducing a reduced lymphocyte proliferative response to a Major Histocomatibilty Complex (MHC) type presented on an human embryonic stem (hES) cell in a subject; induces a state of inflammatory quiescence or immune unresponsiveness, which in turn enhances engraftment of the stem cells
12/22/2005US20050282271 Cell; extracellular, plasma membrane associated cyto-compatible glycoconjugate, a monosaccharide; cancer diagnosis
12/22/2005US20050282256 Adipocyte complement related protein zacrp13
12/22/2005US20050282255 Cell growth differentiation factor (MP52) for use in treatment and prevention of nervous system, dental, skin, connective tissue and bone disorders; wound healing agents
12/22/2005US20050282245 Use of a composition which regulates oxidation/reduction reactions intracellularly and/or extracellularly in a staining or sorting process
12/22/2005US20050282230 Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method
12/22/2005US20050282223 TR3-specific binding agents and methods for their use
12/22/2005US20050282216 Purified polypeptides having IL-13 receptor activity
12/22/2005US20050282201 Cell-based detection and differentiation of lung cancer
12/22/2005US20050282184 Methods and reagents for molecular cloning
12/22/2005US20050282152 Drug testing with bio-artificial organ slices including for example those derived from liver
12/22/2005US20050282150 Identifying an inhibitor of cyclin E2 polypeptide/cyclic-dependent kinase-2 complex formation by allowing a cyclin E2 polypeptide having a specific sequence and cdk2 to spontaneously associate to form a cyclin E2 polypeptide/cdk2 complex; adding test compound; and assaying for a decrease in complex
12/22/2005US20050282148 permit the assessment of agents without administration to subjects; using the artificial immune system of the invention for evaluating the potential reaction of a diseased animal to an agent
12/22/2005US20050282147 Methods for assaying gene imprinting and methylated CpG islands
12/22/2005US20050281831 inhibiting vascularization or angiogenesis using chimeric proteins, immunoglobulin-like domains of tyrosine kinase receptors
12/22/2005US20050281815 CD40 splice variants and their uses
12/22/2005US20050281812 Antibodies to insulin-like growth factor I receptor
12/22/2005US20050281793 T cell activation
12/22/2005US20050281791 Method for inducing cardiac myocytes in embryonic stem (ES) cells by induction with precardiac endoderm and mesoderm
12/22/2005US20050281790 Mesenchymal precursor cell
12/22/2005US20050281789 Transcutaneous and/or transdermal transport of materials
12/22/2005US20050281788 Compositions comprising muscle progenitor cells and uses thereof
12/22/2005US20050279730 Method for manufacturing cell culture substrate
12/22/2005CA2609260A1 Rna-containing microvesicles and methods therefor
12/22/2005CA2573430A1 Anti-perp antibody
12/22/2005CA2570050A1 Heart and skeletal muscle inflammation (hsmi) virus
12/22/2005CA2569978A1 Neural stem cells
12/22/2005CA2566851A1 Compositions comprising female germline stem cells and methods of use thereof
12/22/2005CA2566647A1 Inhibition of macrophage-stimulating protein receptor (ron)
12/22/2005CA2564784A1 Episomal fusion gene
12/22/2005CA2564413A1 Stable composite material comprising supported porous gels
12/22/2005CA2507844A1 Brassica ahas genes and gene alleles that provide resistance to imidazolinone herbicides
12/22/2005CA2469139A1 Potato regeneration system and use thereof
12/22/2005CA2469098A1 Pathogen inducible plant promoter and use thereof
12/21/2005EP1607402A1 Method for the diagnosis of tumour
12/21/2005EP1607108A1 Blood vessel-specific organogenesis from embryonic stem cells on three-dimensional matrigel layer
12/21/2005EP1606396A2 Methods of promoting the differentiation of stem cells
12/21/2005EP1606395A2 Accelerated culture system for intestinal epithelial cell monolayers
12/21/2005EP1606388A2 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
12/21/2005EP1606065A2 Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon
12/21/2005EP1605982A2 Compositions for neuronal tissue regeneration
12/21/2005EP1605965A1 Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome
12/21/2005EP1576086A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/21/2005EP1534754A4 Bi-specific antigen-binding compositions and related methods
12/21/2005EP1509087A4 Treatment for diabetes